Yujun Wu

Yujun Wu has a diverse work experience in the field of biostatistics and programming. Currently, they hold the position of Vice President and Head of Biostatistics and Programming at Morphic Therapeutic, starting in February 2024. Prior to this role, they were the Executive Director and Head of Biostatistics and Programming at the same company from October 2021 to January 2024.

Before joining Morphic Therapeutic, Yujun Wu worked at Takeda Oncology as a Director from August 2018 to September 2021. Yujun also served as an Adjunct Assistant Professor at the Department of Biostatistics, Rutgers University from 2007 to August 2018.

Yujun Wu has also gained valuable experience at Sanofi, where they held various positions, including Director, Associate Director, Assistant Director, Senior Manager, and Principal Statistician in the field of Biostatistics and Programming from 2007 to 2018.

Furthermore, they worked as an Assistant Professor at the Department of Biostatistics, University of Medicine and Dentistry of New Jersey from 2004 to 2007, and as a Biostatistician at The Cancer Institute of New Jersey from 2004 to 2007.

Yujun Wu holds a Ph.D. in Statistics from North Carolina State University, which was obtained from 2000 to 2004. Prior to that, Wu completed a Bachelor of Science degree in Probability and Statistics at Peking University from 1992 to 1997.